NCT03100006 2022-06-13
ORION-01
National Cancer Centre, Singapore
Phase 1/2 Terminated
Clinical Trials
3 trialsNCT00034138 2007-12-18
A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma
Unither Pharmaceuticals
Phase 1/2 Terminated
NCT00034372 2007-12-18
Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma
Unither Pharmaceuticals
Phase 2 Terminated